Ortho Evra Patch Update

The most recent study concerning the Ortho Evra birth control patch confirms earlier tests that suggested that the patch increases the risk for venous thromboembolism, more commonly known as blood clots, in women aged 15-44 compared to women using birth control pills. Blood clots can lead to a pulmonary embolism.
The label changes are based on a study conducted by the Boston Collaborative Drug Surveillance Program on behalf of Johnson and Johnson. The patch was studied in women aged 15-44. These findings support an earlier study that also said women in this group were at higher risk for blood clots.